Fresh Recalls

FDAClass III · Drug · Recall D-0551-2026 · Recalled June 3, 2026

PRED MILD recall — AbbVie Inc.

Agency report date: June 3, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
PRED MILD
Company / brand
AbbVie
Lot / serial / date codes
Lot # 402805, 407596, Exp Date: 08/2026.
Distribution
US Nationwide.
Agency product description and boundaries

PRED MILD, prednisolone acetate ophthalmic suspension, USP, 0.12%, 10 mL, Sterile, Rx only, Allergen, Inc., an AbbVie company, North Chicago, IL 60064, Product of France, NDC 11980-174-10.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Failed Stability Specifications

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class III: not likely to cause adverse health consequences.

Affected product: PRED MILD recall status

3. Open the official notice or contact

Official recall ID
D-0551-2026
Brand
All AbbVie recalls
Classification
Class III
Units affected
2,736 bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
North Chicago, IL, United States
Firm address
1 N Waukegan Rd, 60064-1802

Identifying details (verbatim from the notice)

Product codes / lots
Lot # 402805, 407596, Exp Date: 08/2026.
Distribution
US Nationwide.
Firm notified the public via
Letter
FDA event ID
99008
Recall initiated
May 18, 2026
FDA classified
May 27, 2026
FDA report date
June 3, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved September 1, 2026 at 6:00 PM UTC.

Report a data error on this page